00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 100010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100070 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100080 - Disclosure - Organization and Description of Business link:calculationLink link:presentationLink link:definitionLink 100090 - Disclosure - Summary of Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 100100 - Disclosure - Fair Value Measurements link:calculationLink link:presentationLink link:definitionLink 100110 - Disclosure - Balance Sheet Components link:calculationLink link:presentationLink link:definitionLink 100120 - Disclosure - Research Collaboration and License Agreements link:calculationLink link:presentationLink link:definitionLink 100130 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 100140 - Disclosure - Stockholders' Equity link:calculationLink link:presentationLink link:definitionLink 100150 - Disclosure - Income Taxes link:calculationLink link:presentationLink link:definitionLink 100160 - Disclosure - Summary of Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 100170 - Disclosure - Summary of Significant Accounting Policies (Tables) link:calculationLink link:presentationLink link:definitionLink 100180 - Disclosure - Fair Value Measurements (Tables) link:calculationLink link:presentationLink link:definitionLink 100190 - Disclosure - Balance Sheet Components (Tables) link:calculationLink link:presentationLink link:definitionLink 100200 - Disclosure - Research Collaboration and License Agreements (Tables) link:calculationLink link:presentationLink link:definitionLink 100210 - Disclosure - Commitments and Contingencies (Tables) link:calculationLink link:presentationLink link:definitionLink 100220 - Disclosure - Stockholders' Equity (Tables) link:calculationLink link:presentationLink link:definitionLink 100230 - Disclosure - Organization and Description of Business - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100240 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100250 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Life of Asset (Details) link:calculationLink link:presentationLink link:definitionLink 100260 - Disclosure - Summary of Significant Accounting Policies - Computation of Net Loss Per Common Share (Details) link:calculationLink link:presentationLink link:definitionLink 100270 - Disclosure - Summary of Significant Accounting Policies - Computation of Net Loss Per Common Share (Parenthetical) (Details) link:calculationLink link:presentationLink link:definitionLink 100280 - Disclosure - Summary of Significant Accounting Policies - Potentially Dilutive Securities Not Included in the Diluted Net Loss Per Share Calculations (Details) link:calculationLink link:presentationLink link:definitionLink 100290 - Disclosure - Fair Value Measurements - Summary of Cash and Cash Equivalents and Marketable Securities Classified as Available-for-sale Securities (Details) link:calculationLink link:presentationLink link:definitionLink 100300 - Disclosure - Fair Value Measurements - Summary of Cash and Cash Equivalents and Marketable Securities Classified as Available-for-sale Securities (Parenthetical) (Details) link:calculationLink link:presentationLink link:definitionLink 100310 - Disclosure - Fair Value Measurements - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100320 - Disclosure - Fair Value Measurements - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) link:calculationLink link:presentationLink link:definitionLink 100330 - Disclosure - Balance Sheet Components - Schedule of Reconciliation of Cash, Cash Equivalent and Restricted Cash (Details) link:calculationLink link:presentationLink link:definitionLink 100340 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment (Details) link:calculationLink link:presentationLink link:definitionLink 100350 - Disclosure - Balance Sheet Components - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100360 - Disclosure - Balance Sheet Components - Schedule of Accrued Liabilities (Details) link:calculationLink link:presentationLink link:definitionLink 100370 - Disclosure - Research Collaboration and License Agreements - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100380 - Disclosure - Research Collaboration and License Agreements - Schedule of Milestone Payments by Indications (Details) link:calculationLink link:presentationLink link:definitionLink 100390 - Disclosure - Research Collaboration and License Agreements - Schedule of Recognized Revenue from Collaboration and License Agreements (Details) link:calculationLink link:presentationLink link:definitionLink 100400 - Disclosure - Research Collaboration and License Agreements - Schedule of Changes in Related Party Contract Liabilities (Details) link:calculationLink link:presentationLink link:definitionLink 100410 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100420 - Disclosure - Commitments and Contingencies - Future Minimum Commitments under Unassigned Lease Obligations (Details) link:calculationLink link:presentationLink link:definitionLink 100430 - Disclosure - Stockholders' Equity - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100440 - Disclosure - Stockholders' Equity - Schedule of Shares of Common Stock Reserved for Issuance (Details) link:calculationLink link:presentationLink link:definitionLink 100450 - Disclosure - Stockholders' Equity - Summary of Activity under 2008 Plan and 2018 Plan (Details) link:calculationLink link:presentationLink link:definitionLink 100460 - Disclosure - Stockholders' Equity - Summary of Stock Based Compensation Expense (Details) link:calculationLink link:presentationLink link:definitionLink 100470 - Disclosure - Income Taxes - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink